| Heading: |
Drugs: Side Effects |
| Question ID: |
1820771 |
| UIN: |
65740 |
| House: |
Commons |
| Date tabled: |
2025-07-08 |
| Asking Member ID: |
1506 |
| Asking Member display name: |
Andrew Gwynne
|
| Asking Member handle: |
GwynneMP
|
| Asking Member Twitter reference: |
@GwynneMP
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps he is taking to increase public awareness of (a) which medicines are known to have teratogenous effects and (b) the risks of taking teratogenous medicines during pregnancy. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-08-08 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The product information for each medicine possibly associated with teratogenic effects includes details about the nature and severity of the risk. The product information is intended to support and not replace the discussion between a healthcare professio... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |